City of San Francisco Finalizes Landmark $267 Million Opioid Settlement

In a landmark settlement agreement, two major pharmaceutical companies and a retailer will pay San Francisco over $267 million in the next 15 years to resolve allegations of their complicity in fueling the city’s opioid crisis.

On Tuesday, the city’s Board of Supervisors unanimously approved a settlement agreement between the city and county of San Francisco and Walgreens, Teva Pharmaceuticals and Allergan Finance.

The three companies agreed to pay a collective $267 million in settlement fees for a 2018 lawsuit, with Walgreens taking the largest share at a whopping $229.6 million.

Read the source article at The San Francisco Standard